vs
丽思卡尔顿酒店集团（INN）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是丽思卡尔顿酒店集团的1.2倍（$207.3M vs $175.0M），丽思卡尔顿酒店集团净利率更高（-1.5% vs -62.0%，领先60.5%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 1.2%），丽思卡尔顿酒店集团自由现金流更多（$73.6M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -3.6%）
丽思卡尔顿酒店集团是源自美国的跨国豪华连锁酒店品牌，主打高端奢华住宿体验，目前在全球30个国家和地区运营着108家豪华酒店及度假村，共计拥有超过2.9万间客房，另有46家合计近9千间客房的项目正在筹备规划中。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
INN vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $175.0M | $207.3M |
| 净利润 | $-2.6M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 8.3% | -54.7% |
| 净利率 | -1.5% | -62.0% |
| 营收同比 | 1.2% | 25.9% |
| 净利润同比 | -381.3% | 3.5% |
| 每股收益（稀释后） | $-0.05 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $175.0M | $207.3M | ||
| Q3 25 | $177.1M | $159.9M | ||
| Q2 25 | $192.9M | $166.5M | ||
| Q1 25 | $184.5M | $139.3M | ||
| Q4 24 | $172.9M | $164.6M | ||
| Q3 24 | $176.8M | $139.5M | ||
| Q2 24 | $193.9M | $147.0M | ||
| Q1 24 | $188.1M | $108.8M |
| Q4 25 | $-2.6M | $-128.6M | ||
| Q3 25 | $-11.8M | $-180.4M | ||
| Q2 25 | $2.0M | $-115.0M | ||
| Q1 25 | $623.0K | $-151.1M | ||
| Q4 24 | $916.0K | $-133.2M | ||
| Q3 24 | $-3.6M | $-133.5M | ||
| Q2 24 | $38.7M | $-131.6M | ||
| Q1 24 | $2.8M | $-170.7M |
| Q4 25 | 8.3% | -54.7% | ||
| Q3 25 | 4.8% | -106.9% | ||
| Q2 25 | 11.8% | -64.8% | ||
| Q1 25 | 10.7% | -102.6% | ||
| Q4 24 | 4.6% | -74.3% | ||
| Q3 24 | 8.9% | -94.6% | ||
| Q2 24 | 29.0% | -79.1% | ||
| Q1 24 | 12.5% | -151.9% |
| Q4 25 | -1.5% | -62.0% | ||
| Q3 25 | -6.6% | -112.8% | ||
| Q2 25 | 1.1% | -69.0% | ||
| Q1 25 | 0.3% | -108.5% | ||
| Q4 24 | 0.5% | -80.9% | ||
| Q3 24 | -2.0% | -95.7% | ||
| Q2 24 | 20.0% | -89.5% | ||
| Q1 24 | 1.5% | -156.8% |
| Q4 25 | $-0.05 | $-1.28 | ||
| Q3 25 | $-0.11 | $-1.81 | ||
| Q2 25 | $-0.02 | $-1.17 | ||
| Q1 25 | $-0.04 | $-1.57 | ||
| Q4 24 | $0.05 | $-1.34 | ||
| Q3 24 | $-0.04 | $-1.40 | ||
| Q2 24 | $0.23 | $-1.52 | ||
| Q1 24 | $-0.02 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.1M | $421.0M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $862.2M | $-80.0M |
| 总资产 | $2.8B | $1.5B |
| 负债/权益比越低杠杆越低 | 1.62× | — |
8季度趋势，按日历期对齐
| Q4 25 | $36.1M | $421.0M | ||
| Q3 25 | $41.1M | $202.5M | ||
| Q2 25 | $39.5M | $176.3M | ||
| Q1 25 | $48.2M | $127.1M | ||
| Q4 24 | $40.6M | $174.0M | ||
| Q3 24 | $51.7M | $150.6M | ||
| Q2 24 | $45.9M | $480.7M | ||
| Q1 24 | $63.4M | $112.3M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $862.2M | $-80.0M | ||
| Q3 25 | $875.8M | $9.2M | ||
| Q2 25 | $895.1M | $151.3M | ||
| Q1 25 | $920.4M | $144.2M | ||
| Q4 24 | $909.5M | $255.0M | ||
| Q3 24 | $911.4M | $346.8M | ||
| Q2 24 | $931.9M | $432.4M | ||
| Q1 24 | $907.8M | $140.3M |
| Q4 25 | $2.8B | $1.5B | ||
| Q3 25 | $2.8B | $1.2B | ||
| Q2 25 | $2.9B | $1.3B | ||
| Q1 25 | $2.9B | $1.3B | ||
| Q4 24 | $2.9B | $1.5B | ||
| Q3 24 | $2.8B | $1.5B | ||
| Q2 24 | $2.9B | $1.6B | ||
| Q1 24 | $3.0B | $1.3B |
| Q4 25 | 1.62× | — | ||
| Q3 25 | 1.62× | — | ||
| Q2 25 | 1.59× | — | ||
| Q1 25 | 1.54× | — | ||
| Q4 24 | 1.54× | — | ||
| Q3 24 | 1.47× | — | ||
| Q2 24 | 1.44× | — | ||
| Q1 24 | 1.60× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $149.0M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $73.6M | $-100.8M |
| 自由现金流率自由现金流/营收 | 42.0% | -48.6% |
| 资本支出强度资本支出/营收 | 43.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $137.6M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $149.0M | $-99.8M | ||
| Q3 25 | $45.8M | $-91.4M | ||
| Q2 25 | $48.8M | $-108.3M | ||
| Q1 25 | $25.9M | $-166.5M | ||
| Q4 24 | $166.3M | $-79.3M | ||
| Q3 24 | $55.7M | $-67.0M | ||
| Q2 24 | $50.3M | $-77.0M | ||
| Q1 24 | $28.1M | $-190.7M |
| Q4 25 | $73.6M | $-100.8M | ||
| Q3 25 | $24.0M | $-92.7M | ||
| Q2 25 | $30.0M | $-110.7M | ||
| Q1 25 | $10.1M | $-167.8M | ||
| Q4 24 | $77.0M | $-79.5M | ||
| Q3 24 | $33.1M | $-68.6M | ||
| Q2 24 | $29.4M | $-79.0M | ||
| Q1 24 | $10.0M | $-193.9M |
| Q4 25 | 42.0% | -48.6% | ||
| Q3 25 | 13.5% | -58.0% | ||
| Q2 25 | 15.5% | -66.5% | ||
| Q1 25 | 5.5% | -120.5% | ||
| Q4 24 | 44.5% | -48.3% | ||
| Q3 24 | 18.7% | -49.2% | ||
| Q2 24 | 15.2% | -53.7% | ||
| Q1 24 | 5.3% | -178.2% |
| Q4 25 | 43.1% | 0.5% | ||
| Q3 25 | 12.3% | 0.8% | ||
| Q2 25 | 9.8% | 1.5% | ||
| Q1 25 | 8.5% | 1.0% | ||
| Q4 24 | 51.6% | 0.1% | ||
| Q3 24 | 12.7% | 1.2% | ||
| Q2 24 | 10.8% | 1.4% | ||
| Q1 24 | 9.6% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 23.97× | — | ||
| Q1 25 | 41.49× | — | ||
| Q4 24 | 181.58× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.30× | — | ||
| Q1 24 | 9.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INN
| Occupancy | $153.1M | 88% |
| Food And Beverage | $11.0M | 6% |
| Other | $10.8M | 6% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
